Investigation and Analysis of Non-ABO Hemolytic Disease of the Newborn.
10.19746/j.cnki.issn.1009-2137.2021.04.050
- Author:
Yan-Ling ZHENG
1
;
Qiang HONG
1
;
Qian-Ming WANG
2
,
3
Author Information
1. Department of Blood Transfusion, The First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian Province, China.
2. Department of Clinical Laboratory, The First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian Province, China,E-mail: wangqm111@
3. com.
- Publication Type:Journal Article
- MeSH:
ABO Blood-Group System;
Blood Group Incompatibility;
Coombs Test;
Erythroblastosis, Fetal;
Female;
Humans;
Infant, Newborn;
Male;
Pregnancy;
Retrospective Studies
- From:
Journal of Experimental Hematology
2021;29(4):1330-1333
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the serological detection characteristics and antibody specific distribution of hemolytic disease of the newborn (HDN) caused by irregular antibodies through retrospective case analysis.
METHODS:A total of 3 047 suspected cases of HDN were submitted by the Neonatal Department of our hospital from January 2014 to December 2019. Non ABO-HDN cases confirmed in our laboratory were taken as the research objects, while some cases of ABO-HDN were randomly selected as control. Disease-causing antibody specificity, serological detection characteristics, total bilirubin change trend and gender ratio of non ABO-HDN patients were explored.
RESULTS:Sixty-seven cases of non ABO-HDN were confirmed from the suspected cases of HDN, Among which 45 males and 22 females were detected with the positive rate 1.48% and 0.72%, respectively. The mothers of 65 cases had two or more pregnancies. The detected irregular antibodies were mainly involved with Rh system, MNS system, Kidd system and Lewis system, among which Rh system accounted for 88.07% of the total antibody detection rate. Compared with that of ABO-HDN patients, the total bilirubin of non ABO-HDN patients developed more rapidly with a higher peak and a longer duration (P<0.001). In terms of serological detection, the positive rate of non ABO-HDN direct antibody test was 97.01%, which was higher than 47.00% of ABO-HDN (P<0.001), and the agglutination strength was often ≥ 2+, but there were still weak positive or negative cases of direct antibody test.
CONCLUSION:Non ABO-HDN caused by irregular antibodies mostly occurs in fetuses whose mothers experience multiple pregnancies, and the number of males is more than females. The irregular antibodies detected are mainly attributed to Rh system. The peak value of bilirubin in non ABO-HDN patients is higher and lasts longer than that in ABO-HDN patients. Direct antiglobulin test may be used to roughly distinguish ABO-HDN from non ABO-HDN.
